Chinese Expert Consensus on Perioperative Medication in Laser Corneal Refractive Surgeries (2019).
- Author:
Ying LI
1
;
Yan WANG
2
Author Information
- Publication Type:Journal Article
- MeSH: Anti-Bacterial Agents/therapeutic use*; Anti-Inflammatory Agents, Non-Steroidal/therapeutic use*; Asian People/statistics & numerical data*; China; Consensus; Cornea/surgery*; Drug Therapy/methods*; Expert Testimony; Glucocorticoids/therapeutic use*; Humans; Lasers; Ophthalmic Solutions/therapeutic use*; Perioperative Care; Refractive Errors/therapy*; Refractive Surgical Procedures/methods*
- From: Chinese Medical Sciences Journal 2020;35(1):1-12
- CountryChina
- Language:English
- Abstract: Laser corneal refractive surgery has become an important treatment to correct ametropia in recent years. Rational medication in the perioperative period is essential to ensure the success of the surgery and to reduce complications. However, in this area there has been no consistent understanding and unified application guide across the world. Experts in Refractive Surgery Group, Ocular Microcirculation Branch of Chinese Society of Microcirculation who are specialized in keratology and optometry had initiated extensive and rigorous discussions and reached a consensus on appropriate medication before, during and after the refractive surgeries. The consensus covers a broad spectrum of commonly used ophthalmic solutions, provides recommendations of routine and enhanced medication on prevention and management of adverse reactions and complications related to the laser corneal refractive surgeries. We hope the consensus serves as a standard perioperative medication regimen for ophthalmologists, helps to ensure the safety and effectiveness of laser corneal refractive surgeries, and improves the quality and outcome of the refractive surgeries.
